Global Total Other Income Expense Net from 2010 to 2024

MEDANTA Stock   1,125  8.80  0.78%   
Global Health's Total Other Income Expense Net is decreasing over the years with slightly volatile fluctuation. Overall, Total Other Income Expense Net is projected to go to about -5.2 B this year. From 2010 to 2024 Global Health Total Other Income Expense Net quarterly data regression line had arithmetic mean of (1,673,702,233) and r-squared of  0.33. View All Fundamentals
 
Total Other Income Expense Net  
First Reported
2010-12-31
Previous Quarter
-5.4 B
Current Value
-5.2 B
Quarterly Volatility
1.9 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Global Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Global Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 B, Selling General Administrative of 5.3 B or Selling And Marketing Expenses of 306.4 M, as well as many indicators such as . Global financial statements analysis is a perfect complement when working with Global Health Valuation or Volatility modules.
  
This module can also supplement various Global Health Technical models . Check out the analysis of Global Health Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Global Stock

Global Health financial ratios help investors to determine whether Global Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Global with respect to the benefits of owning Global Health security.